Comparison of Neuroprotection by Propofol and Desflurane for POCD Following Subarachnoid Hemorrhage Surgery
Comparison Of Pharmacological Neuroprotection Provided By PROPOFOL VERSUS DESFLURANE For Long Term Postoperative Cognitive Dysfunction In Patients Undergoing Surgery For Aneurysmal Subarachnoid Hemorrhage
1 other identifier
interventional
100
1 country
1
Brief Summary
Aneurysmal subarachnoid hemorrhage (aSAH) is characterized by the rupture of an intracranial aneurysm and accumulation of blood in the subarachnoid space with 30 to 40% mortality rate. Amongst the survivors 40-50% suffers disability due to cognitive decline.Trends towards early surgery offers challenge to anesthesiologist to provide optimum brain relaxation and simultaneously maintaining stable hemodynamics. Anesthetic agents are administered to conduct smooth neurosurgical procedure. These agents may affect patient's cognitive function postoperatively.Currently most common anesthetic agents used are either intravenous hypnotic agents (propofol) or volatile inhalational agents (isoflurane/sevoflurane/desflurane). Provision of neuroprotection with propofol and volatile inhalational agents has been studied by various authors.Not many studies have been performed in patients undergoing aneurysmal clipping surgeries looking into effects of various anesthetic agents on intraoperative (I/O) brain condition, I/O hemodynamic and POCD.Thus present study is planned to compare propofol and desflurane for long term postoperative cognitive decline in patients undergoing surgery following aneurysmal subarachnoid hemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 13, 2016
CompletedFirst Posted
Study publicly available on registry
December 8, 2016
CompletedDecember 8, 2016
December 1, 2016
1.3 years
November 13, 2016
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of cognitive function at one month following surgery.
Montreal Cognitive Assessment scale is used
One month
Secondary Outcomes (3)
Assessment of cognitive function preoperatively Assessment of cognitive function at discharge. Comparison of biomarker of cognitive dysfunction
Baseline cognition assessment prior to surgery
Assessment of cognitive function preoperatively Assessment of cognitive function at the time of discharge from hospital
Discharge from hospital
Comparison of biomarker (S-100B) levels
Prior to surgery , After clipping of aneurysm, One hour after completion of surgery
Study Arms (2)
PROPOFOL
ACTIVE COMPARATORIntravenous hypnotic agent Decrease Cerebral Metabolic reduction Decrease ICP(Intracranial pressure) Better cognitive Function preservation
DESFLURANE
ACTIVE COMPARATORInhalational agent. Decreases cerebral metabolism Increase /decreases ICP Cognition preservation
Interventions
Intravenous hypnotic agent Decrease Cerebral Metabolic reduction Decrease ICP Better cognitive Function preservation
Inhalational agent. Decreases cerebral metabolism Increase /decreases ICP Cognition preservation
Eligibility Criteria
You may qualify if:
- Patients scheduled for aneurysmal SAH surgery with clinical and radiological evidence of cerebral aneurysm.
- Age between 18 to 65 yrs.
- World Federation of neurosurgery grade 1, 2.
- American society of Anesthesia grade 1, 2 and 3.
You may not qualify if:
- Co-morbidities other than hypertension and diabetes mellitus like cardiovascular disease and respiratory impairment.
- Patients with known psychiatric disease.
- History of drug abuse.
- Low level of education (illiterate) or multiple failures in school.
- Patients who are unconscious, intubated or tracheostomised even after two weeks following exposure to anesthesia will also be excluded from the study.
- Intraoperative complications like massive blood loss, prolonged clipping time(\>20minutes), severe intraoperative brain swelling precluding replacement of bone flap.
- Patients with infectious diseases and respiratory complications.
- Multiple surgeries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Postgraduate institute of medical education and research
Chandigarh, Chandigarh, 160012, India
Related Publications (1)
Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators. Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7. doi: 10.1136/jnnp-2012-302217. Epub 2012 Jul 31.
PMID: 22851612RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shalvi Mahajan, MD
Post Graduate Institute of Medical Education and Research, Chandigarh
- PRINCIPAL INVESTIGATOR
Hemant Bhagat, DM
Post Graduate Institute of Medical Education and Research, Chandigarh
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Resident
Study Record Dates
First Submitted
November 13, 2016
First Posted
December 8, 2016
Study Start
July 1, 2015
Primary Completion
October 1, 2016
Study Completion
November 1, 2016
Last Updated
December 8, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will share